技術指標
指標
數值
方向
MACD(12,26,9)
-0.180
賣出
RSI(14)
39.980
中性
STOCH(KDJ)(9,3,3)
25.034
中性
ATR(14)
0.276
低波動
CCI(14)
-87.739
中性
Williams %R
80.631
超賣
TRIX(12,20)
-0.341
賣出
StochRSI(14)
0.000
超賣
搜尋
Alterity Therapeutics Ltd
ATHE添加自選
4.415USD
-0.070-1.56%
收盤 07-31 16:00（美東）報價延遲15分鐘
67.16M總市值
虧損本益比TTM
關鍵數據
4.340今開
4.780最高
3.79K成交量
虧損本益比TTM
虧損本益比動
--股利TTM
0.02%換手率
4.495昨收
4.340最低
11.95K成交額
虧損本益比靜
2.41市淨率
0.00%股息率 TTM
-36.47%ROA
7.00052週最高
0.88量比
-7.86M淨利潤
15.21M總股本
-0.7380每股盈餘TTM
0.32Beta
-42.37%ROE
2.66052週最低
9.79%振幅
100.00%毛利率
67.16M總市值
-6.57回報/風險
3.61%風險率
Alterity Therapeutics Ltd新聞
即將為您帶來更多新聞，敬請期待。 。 。
收益預測
分析師評級
基於
3
分析師
買入
評級
12.667
目標均價
+185.29%
漲幅空間
強力買入
買入
持有
賣出
強力賣出
同行比較
496
總數
6
中位數
7
平均值
公司名稱
評級分佈
分析師數
Alterity Therapeutics Ltd
ATHE
3
Beigene Ltd
ONC
28
argenx SE
ARGX
26
Ionis Pharmaceuticals Inc
IONS
26
IQVIA Holdings Inc
IQV
25
Insmed Inc
INSM
23
1
2
3
...
99
技術指標
移動平均線
指標
數值
方向
MA5
4.516
賣出
MA10
4.623
賣出
MA20
4.973
賣出
MA50
4.675
賣出
MA100
4.350
買入
MA200
3.963
買入
財務指標
每股收益
由於公司未披露，未能獲取相關數據
營業總收入
由於公司未披露，未能獲取相關數據
Alterity Therapeutics Ltd簡介
Alterity Therapeutics Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on developing disease modifying treatments for neurodegenerative diseases. The Company's lead asset, ATH434, is to treat various Parkinsonian disorders. ATH434 is an oral agent designed to inhibit the aggregation of pathological proteins implicated in neurodegeneration. It has the potential to treat Parkinson's disease, as well as various Parkinsonian disorders, such as Multiple System Atrophy (MSA). The Company also has a drug discovery platform generating patentable chemical compounds to intercede in disease processes. ATH434 has been granted Orphan designation for the treatment of MSA. The Phase II clinical trial is a randomized, double-blind, placebo-controlled investigation of ATH434 in patients with early-stage MSA.
公司代碼ATHE
公司Alterity Therapeutics Ltd
CEOStamler (David A)
網址https://alteritytherapeutics.com/
公司股東
相關品種
-0.53%
+0.27%
-0.92%
-2.51%
+0.32%
-1.45%
-0.64%
-0.82%
-8.79%
+0.52%
+0.68%
-0.95%
-0.71%
+0.44%
-1.08%
+3.29%
0.00%
+1.30%
-0.90%
-2.15%熱門品種
52378.000
+109.000 (+0.21%)
28160.900
-37.600 (-0.13%)
7475.100
+30.800 (+0.41%)
14749.000
-90.000 (-0.61%)
62852.000
-742.000 (-1.17%)
6365.400
-1.000 (-0.02%)
85.934
+2.764 (+3.32%)
308.910
-24.520 (-7.35%)
200.750
+5.710 (+2.93%)
4041.430
-61.400 (-1.50%)
常見問題
Alterity Therapeutics Ltd(ATHE)的當前股價是多少？
Alterity Therapeutics Ltd(ATHE)的當前股價是 4.42。
Alterity Therapeutics Ltd 的股票代碼是什麼？
Alterity Therapeutics Ltd的股票代碼是ATHE。
Alterity Therapeutics Ltd股票的52週最高點是多少？
Alterity Therapeutics Ltd股票的52週最高點是7.00。
Alterity Therapeutics Ltd股票的52週最低點是多少？
Alterity Therapeutics Ltd股票的52週最低點是2.66。
Alterity Therapeutics Ltd的市值是多少？
Alterity Therapeutics Ltd的市值是67.16M。
現在Alterity Therapeutics Ltd(ATHE)的股票是買入、持有還是賣出？
根據分析師評級，Alterity Therapeutics Ltd(ATHE)的總體評級為買入，目標價格為12.67。
Alterity Therapeutics Ltd(ATHE)股票的每股收益（EPS TTM）是多少
Alterity Therapeutics Ltd(ATHE)股票的每股收益（EPS TTM）是-36.90。